Law
The case No. 12-1539 between Mylan Pharmaceuticals Inc. and GlaxoSmithKline Beecham took place in the United States Court of Appeals for the Third Circuit on the 8th of January, 2013 after an appeal from the United States District Court for the District of New Jersey. The presiding Circuit Judges were Scirica, Ambro and Fuentes. The case involved the competing rights over the pharmaceutical drug paroxetine hydrochloride controlled release tablets in their generic form (Paroxetine Hydrochloride Extended-release (ER) Tablets). The Defendant was SmithKline Beecham Corp currently holding FDA rights and a patent to market and sell the drug paroxetine meant Continue reading...